Does Indoxyl Sulfate Have a Role in Uremic Pruritus?

Itching is a widespread and disturbing complain from patients with chronic kidney disease (CKD); epidemiologic data have suggested that approximately 40% of patients with end-stage renal disease experience moderate to severe itching. The pathogenesis of renal pruritus is multifactorial. Triggering factors may include uremia-related abnormalities, accumulation of uremic toxins, systemic inflammation and cutaneous xerosis. Indoxyl sulfate (IS) is a protein-bound uremic toxin resulting from the metabolism of dietary tryptophan accumulating in patients with end-stage renal disease.

Inclusion Criteria:Patients with end-stage renal failure with itching undergoing regular hemodialysisExclusion Criteria:Patients with other causes of itching as psoriasis, atopic dermatitis, scabies, and lichen planus